BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8542048)

  • 41. The nondystrophic myotonias.
    Heatwole CR; Moxley RT
    Neurotherapeutics; 2007 Apr; 4(2):238-51. PubMed ID: 17395134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The myotonic disorders and the periodic paralyses.
    Griggs RC
    Adv Neurol; 1977; 17():143-59. PubMed ID: 888733
    [No Abstract]   [Full Text] [Related]  

  • 43. Loss of Na+ channel inactivation by anemone toxin (ATX II) mimics the myotonic state in hyperkalaemic periodic paralysis.
    Cannon SC; Corey DP
    J Physiol; 1993 Jul; 466():501-20. PubMed ID: 8105077
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary periodic paralyses.
    Finsterer J
    Acta Neurol Scand; 2008 Mar; 117(3):145-58. PubMed ID: 18031562
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Skeletal-muscle channelopathies: periodic paralysis and nondystrophic myotonias.
    Ryan AM; Matthews E; Hanna MG
    Curr Opin Neurol; 2007 Oct; 20(5):558-63. PubMed ID: 17885445
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic approaches to the nosology of muscular disease: myotonias and similar diseases.
    Becker PE
    Birth Defects Orig Artic Ser; 1971 Feb; 7(2):52-62. PubMed ID: 5293617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Defective slow inactivation of sodium channels contributes to familial periodic paralysis.
    Hayward LJ; Sandoval GM; Cannon SC
    Neurology; 1999 Apr; 52(7):1447-53. PubMed ID: 10227633
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An expanding view for the molecular basis of familial periodic paralysis.
    Cannon SC
    Neuromuscul Disord; 2002 Aug; 12(6):533-43. PubMed ID: 12117476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A zebrafish model of nondystrophic myotonia with sodium channelopathy.
    Nam TS; Zhang J; Chandrasekaran G; Jeong IY; Li W; Lee SH; Kang KW; Maeng JS; Kang H; Shin HY; Park HC; Kim S; Choi SY; Kim MK
    Neurosci Lett; 2020 Jan; 714():134579. PubMed ID: 31669315
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation and inactivation of the voltage-gated sodium channel: role of segment S5 revealed by a novel hyperkalaemic periodic paralysis mutation.
    Bendahhou S; Cummins TR; Tawil R; Waxman SG; Ptácek LJ
    J Neurosci; 1999 Jun; 19(12):4762-71. PubMed ID: 10366610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel insights into the pathomechanisms of skeletal muscle channelopathies.
    Burge JA; Hanna MG
    Curr Neurol Neurosci Rep; 2012 Feb; 12(1):62-9. PubMed ID: 22083238
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Linkage data suggesting allelic heterogeneity for paramyotonia congenita and hyperkalemic periodic paralysis on chromosome 17.
    Koch MC; Ricker K; Otto M; Grimm T; Bender K; Zoll B; Harper PS; Lehmann-Horn F; Rüdel R; Hoffman EP
    Hum Genet; 1991 Nov; 88(1):71-4. PubMed ID: 1660029
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autosomal dominant monosymptomatic myotonia permanens.
    Colding-Jørgensen E; Duno M; Vissing J
    Neurology; 2006 Jul; 67(1):153-5. PubMed ID: 16832098
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Muscle channelopathies.
    Statland J; Phillips L; Trivedi JR
    Neurol Clin; 2014 Aug; 32(3):801-15, x. PubMed ID: 25037091
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Myotonia fluctuans. A third type of muscle sodium channel disease.
    Ricker K; Moxley RT; Heine R; Lehmann-Horn F
    Arch Neurol; 1994 Nov; 51(11):1095-102. PubMed ID: 7980103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Muscle channelopathies and related diseases.
    Fontaine B
    Handb Clin Neurol; 2013; 113():1433-6. PubMed ID: 23622365
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetics, an alternative way to discover, characterize and understand ion channels.
    Schofield PR
    Clin Exp Pharmacol Physiol; 2001; 28(1-2):84-8. PubMed ID: 11153544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spectrum of Nondystrophic Skeletal Muscle Channelopathies in Children.
    Al-Ghamdi F; Darras BT; Ghosh PS
    Pediatr Neurol; 2017 May; 70():26-33. PubMed ID: 28325641
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dinucleotide repeat polymorphisms at the SCN4A locus suggest allelic heterogeneity of hyperkalemic periodic paralysis and paramyotonia congenita.
    McClatchey AI; Trofatter J; McKenna-Yasek D; Raskind W; Bird T; Pericak-Vance M; Gilchrist J; Arahata K; Radosavljevic D; Worthen HG
    Am J Hum Genet; 1992 May; 50(5):896-901. PubMed ID: 1315122
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Confirmation of linkage of hyperkalaemic periodic paralysis to chromosome 17.
    Koch MC; Ricker K; Otto M; Grimm T; Hoffman EP; Rüdel R; Bender K; Zoll B; Harper PS; Lehmann-Horn F
    J Med Genet; 1991 Sep; 28(9):583-6. PubMed ID: 1683408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.